Clinical trial
Pulse Wave Velocity, Pulse Wave Morphology and Blocking of the Reninangiotensin…
NCT00235287 · Herlev Hospital, Other · Unknown status
Key facts
| NCT number | NCT00235287 |
|---|---|
| Title | Pulse Wave Velocity, Pulse Wave Morphology and Blocking of the Reninangiotensin System in Patients With Chronic Kidney Disease |
| Official title | Pulse Wave Velocity, Pulse Wave Morphology and Blocking of the Reninangiotensin System in Patients With Chronic Kidney Disease: An Interventional and Methodological Study |
| Lead sponsor | Herlev Hospital, Other |
| Status | Unknown status |
| Phase | Phase 4 |
| Study type | Interventional |
| Conditions | Kidney Failure, Chronic, Cardiovascular Diseases |
| Intervention type | Drug |
| Interventions | Candesartan and enalapril, candesartan and enalapril |
| Enrollment | 60 |
| Start date | Sep 1, 2005 |
| First posted | Oct 10, 2005 |
| Last update posted | Jan 19, 2009 |
| Countries | Denmark |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: